TickerFacts.

Company research / EHC

Encompass Health Corp (EHC)

Build a valuation ↗↓ Download CSV

CIK 0000785161 · NYSE · Services-Hospitals

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Encompass Health Corp reported revenue of $5.94B. Revenue grew 10.5% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $6.21B.

Key ratios (year ended 2025-12-31)

9.5%
Net margin
23.2%
Return on year-end equity
10.5%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-19

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$6.21B$5.94B$5.37B$4.80B$4.35B$4.01B$3.57B$4.61B$4.28B$3.91B$3.64B
Operating Incomen/an/an/an/a$539.50M$559.60M$563.90M$612.10M$555.20M$578.30M$588.10M
Depreciation & Amortization$346.50M$327.90M$299.60M$273.90M$243.60M$219.60M$203.00M$218.70M$199.70M$183.80M$172.60M
EBITDAn/an/an/an/a$783.10M$779.20M$766.90M$830.80M$754.90M$762.10M$760.70M
Net Income$621.00M$566.20M$455.70M$352.00M$271.00M$412.20M$284.20M$358.70M$292.30M$271.10M$247.60M
EPS (Diluted)n/a$5.54$4.46$3.47$2.70$4.11$2.85$3.61$2.93$2.84$2.59
Total Assets$7.46B$7.09B$6.53B$6.10B$5.64B$6.86B$6.45B$6.08B$5.17B$4.86B$4.68B
Total Liabilities$4.00B$3.81B$3.69B$3.81B$3.77B$4.47B$4.44B$4.15B$3.36B$3.25B$3.61B
Shareholders' Equity$2.60B$2.44B$2.07B$1.65B$1.31B$1.91B$1.59B$1.35B$1.28B$1.15B$735.90M
Cash & Equivalents$107.70M$72.20M$85.40M$69.10M$21.80M$49.40M$185.60M$94.80M$69.20M$54.40M$40.50M
Operating Cash Flow$1.21B$1.18B$1.00B$850.80M$705.80M$715.80M$704.70M$635.30M$762.40M$658.30M$640.20M
Capital Expenditures$799.10M$736.40M$642.50M$583.10M$584.10M$545.70Mn/an/an/an/an/a
Free Cash Flow$413.40M$439.20M$360.30M$267.70M$121.70M$170.10Mn/an/an/an/an/a
Share Repurchases$247.00M$158.00M$31.10M$0$0$0$6.10M$45.90M$0$38.10M$65.60M
Dividends Paid$75.20M$71.10M$62.80M$60.40M$99.00M$112.20M$111.80M$108.70M$100.80M$91.50M$83.80M
Dividends Per Sharen/a$0.72$0.64$0.60$0.86$1.12$1.12$1.10$1.04$0.98$0.94
Weighted Average Diluted Sharesn/a102.20M102.20M101.30M100.40M100.20M99.80M99.40M99.80M99.30M99.50M
EPS (Basic)n/a$5.62$4.53$3.51$2.72$4.15$2.87$3.65$2.98$2.88$2.77

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView